12:00 AM
 | 
Sep 27, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Synercid quinupristin plus dalfopristin regulatory update

The FDA granted marketing approval for Rhone-Poulenc's Synercid injectable streptogramin antibiotic to treat bloodstream...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >